These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11266938)

  • 1. Blockade of CD154 at the time of donor-specific blood transfusion does not improve kidney graft survival in rhesus monkeys.
    Ringers J; Ossevoort M; Haanstra K; Kroczek R; Volk D; Jonker M
    Transplant Proc; 2001; 33(1-2):524. PubMed ID: 11266938
    [No Abstract]   [Full Text] [Related]  

  • 2. Blockade of CD40-CD154 at the time of donor-specific blood transfusion does not lead to prolonged kidney allograft survival in nonhuman primates.
    Ringers J; Haanstra KG; Kroczek RA; Kliem K; Kuhn EM; Wubben J; Ossevoort MA; Volk HD; Jonker M
    Transplantation; 2002 Mar; 73(6):862-6. PubMed ID: 11923684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monotherapy with the novel human anti-CD154 monoclonal antibody ABI793 in rhesus monkey renal transplantation model.
    Kanmaz T; Fechner JJ; Torrealba J; Kim HT; Dong Y; Oberley TD; Schultz JM; Bloom DD; Katayama M; Dar W; Markovits J; Schuler W; Hu H; Hamawy MM; Knechtle SJ
    Transplantation; 2004 Mar; 77(6):914-20. PubMed ID: 15077037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of dose and duration of anti-CD154 antibody therapy in preventing renal allograft rejection in a nonhuman primate model.
    Xu H; Elster E; Batty D; Berning J; Burkly L; Kampen R; Swanson S; Tadaki D; Harlan D; Kirk A
    Transplant Proc; 2001; 33(1-2):223-4. PubMed ID: 11266788
    [No Abstract]   [Full Text] [Related]  

  • 5. Successful conversion from conventional immunosuppression to anti-CD154 monoclonal antibody costimulatory molecule blockade in rhesus renal allograft recipients.
    Cho CS; Burkly LC; Fechner JH; Kirk AD; Oberley TD; Dong Y; Brunner KG; Peters D; Tenhoor CN; Nadeau K; Yagci G; Ishido N; Schultz JM; Tsuchida M; Hamawy MM; Knechtle SJ
    Transplantation; 2001 Aug; 72(4):587-97. PubMed ID: 11544416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blocking of costimulation prevents kidney graft rejection in rhesus monkeys.
    Ossevoort MA; Ringers J; Boon L; Lorré K; van den Hout Y; Kuhn EM; de Boer M; Jonker M; de Waele P
    Transplant Proc; 1998 Aug; 30(5):2165-6. PubMed ID: 9723429
    [No Abstract]   [Full Text] [Related]  

  • 7. Induction of kidney graft acceptance by creating a window of opportunity for immunologic engagement (WOFIE) in rhesus monkeys.
    Jonker M; Slingerland W; Ossevoort M; Kuhn E; Neville D; Friend P; Calne R
    Transplant Proc; 1998 Aug; 30(5):2441-3. PubMed ID: 9723530
    [No Abstract]   [Full Text] [Related]  

  • 8. Randomized trial of three different immunosuppressive regimens to prevent chronic renal allograft rejection.
    Burke GW; Ciancio C; Blomberg BB; Rosen A; Suzart K; Roth D; Kupin W; Esquenazi V; Miller J
    Transplant Proc; 2002 Aug; 34(5):1610-1. PubMed ID: 12176505
    [No Abstract]   [Full Text] [Related]  

  • 9. T cell-specific monoclonal antibodies abrogate the blood transfusion effect on kidney allograft survival in rhesus monkeys.
    den Butter G; Jonker M; Nooij FJ; van Schilfgaarde R; van Es AA
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1461-3. PubMed ID: 3274355
    [No Abstract]   [Full Text] [Related]  

  • 10. Complete withdrawal of immunosuppression in kidney allograft recipients: a prospective study in rhesus monkeys.
    Jonker M; van den Hout Y; Neuhaus P; Ringers J; Kuhn EM; Bruijn JA; Schuurman HJ; Noort R; Bontrop RE; Claas FH; van Rood JJ
    Transplant Proc; 1998 Aug; 30(5):2451-3. PubMed ID: 9723534
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment with the humanized CD154-specific monoclonal antibody, hu5C8, prevents acute rejection of primary skin allografts in nonhuman primates.
    Elster EA; Xu H; Tadaki DK; Montgomery S; Burkly LC; Berning JD; Baumgartner RE; Cruzata F; Marx R; Harlan DM; Kirk AD
    Transplantation; 2001 Nov; 72(9):1473-8. PubMed ID: 11707732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Withdrawal of steroids from a cyclosporine-based regimen: pro.
    Ponticelli C
    Transplant Proc; 1998 Aug; 30(5):1782-4. PubMed ID: 9723281
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term graft survival of living-related kidneys after donor-specific transfusion.
    Otsuka M; Yuzawa K; Takada Y; Taniguchi H; Fukunaga K; Seino K; Todoroki T; Fukao K
    Transplant Proc; 2000 Nov; 32(7):1741-2. PubMed ID: 11119914
    [No Abstract]   [Full Text] [Related]  

  • 14. CD154 is expressed during treatment with calcineurin inhibitors after organ transplantation.
    van Rijen MM; Kuijf ML; Metselaar HJ; Tilanus HW; Bouma GJ; de Weger RA; Jonker M; Kwekkeboom J
    Transplantation; 2002 May; 73(10):1666-72. PubMed ID: 12042657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IDEC-131 (anti-CD154), sirolimus and donor-specific transfusion facilitate operational tolerance in non-human primates.
    Preston EH; Xu H; Dhanireddy KK; Pearl JP; Leopardi FV; Starost MF; Hale DA; Kirk AD
    Am J Transplant; 2005 May; 5(5):1032-41. PubMed ID: 15816883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Costimulation blockade followed by a 12-week period of cyclosporine A facilitates prolonged drug-free survival of rhesus monkey kidney allografts.
    Haanstra KG; Sick EA; Ringers J; Wubben JA; Kuhn EM; Boon L; Jonker M
    Transplantation; 2005 Jun; 79(11):1623-6. PubMed ID: 15940054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A calcineurin antagonist-free induction immunosuppression strategy for delayed graft function in renal transplantation.
    Hong JC; Kahan BD
    Transplant Proc; 2001; 33(1-2):1271-2. PubMed ID: 11267288
    [No Abstract]   [Full Text] [Related]  

  • 18. Prophylactic use of deoxyspergualin improves long-term graft survival in living related renal transplant recipients transfused with donor-specific blood.
    Amada N; Okazaki H; Sato T; Miura S; Ohashi Y
    Transplant Proc; 2001 May; 33(3):2256-7. PubMed ID: 11377520
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy and safety of ABI793, a novel human anti-human CD154 monoclonal antibody, in cynomolgus monkey renal allotransplantation.
    Schuler W; Bigaud M; Brinkmann V; Di Padova F; Geisse S; Gram H; Hungerford V; Kleuser B; Kristofic C; Menninger K; Tees R; Wieczorek G; Wilt C; Wioland C; Zurini M
    Transplantation; 2004 Mar; 77(5):717-26. PubMed ID: 15021835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow-up after induction treatment with monoclonal anti-interleukin-2 receptor antibody (BT563) in kidney allograft recipients: a double-blind, placebo-controlled trial.
    van Gelder T; Zietse R; Yzermans JN; Rischen-Vos J; Vaessen LM; Weimar W
    Transplant Proc; 1996 Dec; 28(6):3221-2. PubMed ID: 8962247
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.